Hübner Christian T, Amin Asmaa K, Dey Daniela, Meyer Robert, Eggermann Thomas
Institute of Human Genetics, Medical Faculty, RWTH Aachen University, Aachen, Germany.
Department of Human Genetics, Medical Research Institute, Alexandria University, Alexandria, Egypt.
Mol Syndromol. 2022 Dec;13(5):402-408. doi: 10.1159/000523877. Epub 2022 Mar 31.
Mosaic variegated aneuploidy syndrome 2 (MVA2) and Noonan syndrome (NS) are 2 genetic disorders with overlapping clinical features, including intrauterine growth retardation, dysmorphic features, and heart defects. Whereas NS is a well-known congenital entity, MVA2 is rare, and only a few cases have been reported in the literature.
We report on the molecular findings in 3 patients with short stature phenotypes from the same family. By considering the clinical overlap between the patients, a common cause for the small stature was assumed in the beginning, but by whole exome analysis (WES) it turned out that the phenotypes were caused by different pathogenic variants in and , respectively. As a result, both MVA2 and NS occurred in the same family.
As our example shows, the parallel occurrence of pathogenic alterations in different genes in the same family constitutes a challenge for the interpretation of WES data and has to be considered. The diagnostic workup illustrates the need for a careful anamnesis and molecular documentation in affected and healthy family members. The knowledge on the different molecular causes underlying the features of the affected family members is the basis for personalised therapeutic managements and can avoid unnecessary burden and even contraindicated therapies; while in patients with NS carrying variants growth hormone treatment leads to height increase, patients with MVA2 carrying probably do not benefit from it.
镶嵌杂合非整倍体综合征2(MVA2)和努南综合征(NS)是两种具有重叠临床特征的遗传性疾病,包括宫内生长迟缓、畸形特征和心脏缺陷。虽然NS是一种广为人知的先天性疾病,但MVA2很罕见,文献中仅报道了少数病例。
我们报告了来自同一家族的3例身材矮小表型患者的分子学发现。最初,考虑到患者之间的临床重叠情况,认为身材矮小存在共同原因,但通过全外显子组分析(WES)发现,这些表型分别由 和 中的不同致病变异引起。结果,同一个家族中同时出现了MVA2和NS。
正如我们的例子所示,同一家族中不同基因的致病性改变同时出现,给WES数据的解读带来了挑战,必须加以考虑。诊断检查表明,对患病和健康的家庭成员进行仔细的病史采集和分子记录是必要的。了解受影响家庭成员特征背后的不同分子原因,是个性化治疗管理的基础,可以避免不必要的负担甚至禁忌疗法;虽然携带 变异的NS患者生长激素治疗可导致身高增加,但携带 的MVA2患者可能无法从中受益。